-
Neurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
05 Jan 2026 21:27 GMT
… approximately one month.
About Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience- … , classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as … AbbVie)
NEUROCRINE, the NEUROCRINE BIOSCIENCES Logo and YOU DESERVE …
-
Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy
23 Dec 2025 00:15 GMT
… in 2026.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as … collaboration with AbbVie)
The NEUROCRINE BIOSCIENCES logo, NEUROCRINE, YOU DESERVE …
-
Neurocrine Biosciences to Present at Upcoming Investor Conferences
11 Nov 2025 21:25 GMT
… approximately one month.
About Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience- … , classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as … AbbVie)
NEUROCRINE, the NEUROCRINE BIOSCIENCES Logo and YOU DESERVE …
-
Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views
05 Sep 2025 13:51 GMT
… Neurocrine Biosciences analyst ratings.
All You Need to Know About Neurocrine Biosciences
Neurocrine Biosciences … endometriosis; and Oriahnn capsules to treat uterine fibroids.
Understanding the Numbers: Neurocrine Biosciences … Neurocrine Biosciences …
-
The Analyst Verdict: Neurocrine Biosciences In The Eyes Of 17 Experts
31 Jul 2025 20:34 GMT
… on Neurocrine Biosciences analyst ratings.
Get to Know Neurocrine Biosciences Better
Neurocrine Biosciences … hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules … capacity.
Revenue Growth: Neurocrine Biosciences's remarkable performance …
-
Neurocrine Biosciences Grows Pipeline While Maintaining Steady Investor Confidence
28 Jul 2025 19:41 GMT
… raising the price target. Neurocrine Biosciences Grows Pipeline While Maintaining Steady … patient with a neurological disorder. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) develops … ’s chorea, adrenal hyperplasia, endometriosis, and uterine fibroids. The …
-
Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia
20 Jun 2025 12:46 GMT
…
INGREZZA, developed by Neurocrine Biosciences, selectively inhibits VMAT2 with … Medication Guide.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* …
-
Neurocrine Biosciences Appoints Lewis Choi As Chief Information Officer
09 Jun 2025 21:32 GMT
… University of California, Berkeley.
About Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience-focused … disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as well …
-
Analyst Expectations For Neurocrine Biosciences's Future
02 Jun 2025 21:08 GMT
… recent developments related to Neurocrine Biosciences. This information offers … on Neurocrine Biosciences analyst ratings.
Discovering Neurocrine Biosciences: A Closer Look
Neurocrine Biosciences … ; Orilissa tablets for endometriosis; and Oriahnn capsules …
-
Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
28 May 2025 20:30 GMT
… visit ClinicalTrials.gov.
About Neurocrine Biosciences' Muscarinic Portfolio
In … health impacts.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as …
About
© 1995-2026